BIOCENTECH APS: Financial statements 2022
CVR: 25437470
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
BIOCENTECH APS (CVR 25437470) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -5,000 and a net result of DKK -6,314 compared with DKK -7,474 the year before. Equity in the 2022 report amounted to DKK 2,964. The solvency ratio was 3.7%.
- Gross Profit
- DKK -5,000
- Profit/Loss
- DKK -6,314
- Equity
- DKK 2,964
- Total Assets
- DKK 79,165
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -5 t. | -6 t. | 3 t. | - |
| 2021 | - | -6 t. | -7 t. | 9 t. | - |
| 2020 | - | -6 t. | -7 t. | 17 t. | - |
| 2019 | - | -5 t. | -5 t. | 24 t. | - |
| 2018 | - | -8 t. | -7 t. | 28 t. | - |
Official annual report
Keep an eye on BIOCENTECH APS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BIOCENTECH APS has published its annual report for 2021. Gross profit came to DKK -6,250, and the net result was DKK -7,474.
About BIOCENTECH APS
BIOCENTECH APS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Aleksander Nærvig. The company is owned by NÆRVIG GROUP ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,000 and a net result of DKK -14,669 compared with DKK -19,363 the year before. Equity in the 2025 report amounted to DKK -61,305.